Bausch Health Companies Inc (BHC):企業の財務・戦略的SWOT分析

◆英語タイトル:Bausch Health Companies Inc (BHC) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH3707FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:79
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Bausch Health Companies Inc (BHC) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Bausch Health Companies Inc (Bausch Health), formerly Valeant Pharmaceuticals International Inc, manufactures, develops and markets range of medical devices, over-the-counter products (OTC) and pharmaceutical products. Bausch Health offers products in the areas of dermatology, gastroenterology, eye health, neurology, aesthetic devices, dentistry and consumer health. It offers generic and branded generic products. Bausch Health has administrative, research/laboratory, marketing, distribution and warehousing facilities worldwide. The company offers products directly or indirectly in various regions across the world including the US, Canada, Africa, Middle East, Australia, Latin America, and Europe. Bausch Health is headquartered in Laval, Quebec, Canada.

Bausch Health Companies Inc Key Recent Developments

Apr 09,2021: Bausch Health will Release First-Quarter 2021 Financial Results on May 4, 2021
Mar 11,2021: Bausch Health Announces CFO Succession Plan
Feb 24,2021: Bausch Health announces agreement with Carl C. Icahn
Feb 24,2021: Bausch Health Companies announces fourth-quarter and full-year 2020 results and provides 2021 guidance
Jan 12,2021: Bausch Health provides preliminary update on fourth-quarter and full-year 2020 financial results and business recovery

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Bausch Health Companies Inc – Key Facts
Bausch Health Companies Inc – Key Employees
Bausch Health Companies Inc – Key Employee Biographies
Bausch Health Companies Inc – Major Products and Services
Bausch Health Companies Inc – History
Bausch Health Companies Inc – Company Statement
Bausch Health Companies Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Bausch Health Companies Inc – Business Description
Product Category: Branded and Other Generics
Performance
Product Category: Devices
Performance
Product Category: OTC
Performance
Product Category: Other Revenues
Performance
Product Category: Pharmaceuticals
Performance
Product Category: Bausch + Lomb/International
Overview
Performance
Product Category: Diversified Products
Overview
Performance
Product Category: Ortho Dermatologics
Overview
Performance
Product Category: Salix
Overview
Performance
Geographical Segment: Canada
Performance
Geographical Segment: China
Performance
Geographical Segment: Egypt
Performance
Geographical Segment: France
Performance
Geographical Segment: Germany
Performance
Geographical Segment: Japan
Performance
Geographical Segment: Mexico
Performance
Geographical Segment: Others
Performance
Geographical Segment: Poland
Performance
Geographical Segment: Russia
Performance
Geographical Segment: Spain
Performance
Geographical Segment: United Kingdom
Performance
Geographical Segment: US and Puerto Rico
Performance
R&D Overview
Bausch Health Companies Inc – Corporate Strategy
Bausch Health Companies Inc – SWOT Analysis
SWOT Analysis – Overview
Bausch Health Companies Inc – Strengths
Bausch Health Companies Inc – Weaknesses
Bausch Health Companies Inc – Opportunities
Bausch Health Companies Inc – Threats
Bausch Health Companies Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences, Power Financial Deals and Alliances
Bausch Health Companies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Bausch Health Companies Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Bausch Health Companies Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 09, 2021: Bausch Health will Release First-Quarter 2021 Financial Results on May 4, 2021
Mar 11, 2021: Bausch Health Announces CFO Succession Plan
Feb 24, 2021: Bausch Health announces agreement with Carl C. Icahn
Feb 24, 2021: Bausch Health Companies announces fourth-quarter and full-year 2020 results and provides 2021 guidance
Jan 12, 2021: Bausch Health provides preliminary update on fourth-quarter and full-year 2020 financial results and business recovery
Dec 29, 2020: Bausch Health to reduce debt by $275 million
Nov 18, 2020: Bausch Health announces launch of private offering of senior notes and conditional redemption of existing senior notes
Nov 18, 2020: Bausch Health announces pricing and upsize of private offering of senior notes and conditional redemption of additional series of existing senior notes
Nov 11, 2020: Salix to present data at AASLD’s The Liver Meeting Digital Experience
Nov 03, 2020: Bausch Health Companies announces third-quarter 2020 results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Bausch Health Companies Inc, Key Facts
Bausch Health Companies Inc, Key Employees
Bausch Health Companies Inc, Key Employee Biographies
Bausch Health Companies Inc, Major Products and Services
Bausch Health Companies Inc, History
Bausch Health Companies Inc, Other Locations
Bausch Health Companies Inc, Subsidiaries
Bausch Health Companies Inc, Key Competitors
Bausch Health Companies Inc, Ratios based on current share price
Bausch Health Companies Inc, Annual Ratios
Bausch Health Companies Inc, Annual Ratios (Cont...1)
Bausch Health Companies Inc, Annual Ratios (Cont...2)
Bausch Health Companies Inc, Interim Ratios
Bausch Health Companies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Bausch Health Companies Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Bausch Health Companies Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Bausch Health Companies Inc (BHC):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Linde AG (LIN):石油・ガス:M&Aディール及び事業提携情報
    Summary Linde AG (Linde) is a provider of industrial gases and engineering services. The company specializes in the planning, procurement, construction and operation of gas production and processing plants. It offers a wide range of compressed, liquefied gases and chemicals. It also offers engineeri …
  • Grupo Nutresa SA (NUTRESA):企業の財務・戦略的SWOT分析
    Grupo Nutresa SA (NUTRESA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Black Hills Corp (BKH):電力:M&Aディール及び事業提携情報
    Summary Black Hills Corp (BHC) is a vertically-integrated energy company which offers electricity and natural gas. The company produces, transmits, and distributes electricity; and sells natural gas on retail and wholesale basis. It generates electricity from natural gas, coal, diesel oil, and wind …
  • Classic Cosmetics, Inc:企業の戦略・SWOT・財務情報
    Classic Cosmetics, Inc - Strategy, SWOT and Corporate Finance Report Summary Classic Cosmetics, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Bellerophon Therapeutics Inc (BLPH):医療機器:M&Aディール及び事業提携情報
    Summary Bellerophon Therapeutics Inc (Bellerophon Therapeutics), formerly Bellerophon Therapeutics LLC is a clinical-stage biotherapeutics company that focuses on the development of therapies for the treatment of cardiopulmonary diseases. The company’s lead investigational cardiopulmonary product ca …
  • Wirecard AG:企業のM&A・事業提携・投資動向
    Wirecard AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Wirecard AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Cavium Inc:企業の戦略的SWOT分析
    Cavium Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Prudential Plc:戦略・SWOT・企業財務分析
    Prudential Plc - Strategy, SWOT and Corporate Finance Report Summary Prudential Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Fugro GeoServices Ltd:企業の戦略的SWOT分析
    Fugro GeoServices Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • RayBiotech Inc-製薬・医療分野:企業M&A・提携分析
    Summary RayBiotech Inc (RayBiotech) is a life science company that offers proteins, antibodies and immunological kits. The company’s products include antibody arrays, elisa, functional assays, antibodies and custom recombinant protein service. It provides services such as testing services, custom se …
  • Bayer Taiwan Co Ltd:企業の戦略的SWOT分析
    Bayer Taiwan Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • State Atomic Energy Corporation Rosatom-エネルギー分野:企業M&A・提携分析
    Summary State Atomic Energy Corporation Rosatom (ROSATOM), the Russian Federation national nuclear corporation, is a nuclear company that integrates nuclear companies and R&D institutions which operate in the civilian and defense sectors. It provides a variety of nuclear services that range from ura …
  • Shanghai Kehua Bio-engineering Co Ltd (002022):医療機器:M&Aディール及び事業提携情報
    Summary Shanghai Kehua Bio-engineering Co Ltd (KHB) is a medical device company that develops, manufactures and markets in vitro diagnostic devices and related products. The company’s major product portfolio includes enzyme immunoassay kits, clinical chemistry reagents, PCR kits, rapid test kits, ch …
  • Mistras Group Inc (MG):企業の財務・戦略的SWOT分析
    Summary Mistras Group Inc (Mistras) is a provider of technology-enabled asset protection solutions that offers used to evaluate the structural integrity of critical energy, industrial and public infrastructure. The company provides products such as acoustic emission, ultrasonic, and vibration and Pd …
  • A&D Company Ltd (7745):企業の財務・戦略的SWOT分析
    Summary A&D Company Ltd (A&D Company) is a medical equipment company that manufactures, designs, develops, and distributes advanced measuring, controlling, monitoring, and testing instruments. The company’s products include powertrain testing systems, digital analog converter, DSP platform, model ba …
  • Global Investment House KPSC:企業の戦略的SWOT分析
    Global Investment House KPSC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Plexus Corp (PLXS):企業の財務・戦略的SWOT分析
    Plexus Corp (PLXS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • NIBC Bank NV:電力:M&Aディール及び事業提携情報
    Summary NIBC Bank NV (NIBC), a subsidiary of NIBC Holding NV, is an enterprising bank that provides a range of corporate and consumer banking services. The company specializes in mergers and acquisitions, debt and equity mezzanine, capitalization advisory, leveraged finance and structured finance, a …
  • Progress Software Corp (PRGS):企業の財務・戦略的SWOT分析
    Progress Software Corp (PRGS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Nikon Corporation:企業の戦略・SWOT・財務分析
    Nikon Corporation - Strategy, SWOT and Corporate Finance Report Summary Nikon Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆